COYA
Price:
$6.77
Market Cap:
$103.05M
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination f...[Read more]
Industry
Biotechnology
IPO Date
2022-12-29
Stock Exchange
NASDAQ
Ticker
COYA
According to Coya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 66.47M. This represents a change of 1.67% compared to the average of 65.38M of the last 4 quarters.
The mean historical Enterprise Value of Coya Therapeutics, Inc. over the last ten years is 43.07M. The current 66.47M Enterprise Value has changed 15.34% with respect to the historical average. Over the past ten years (40 quarters), COYA's Enterprise Value was at its highest in in the March 2024 quarter at 105.70M. The Enterprise Value was at its lowest in in the March 2021 quarter at 0.
Average
43.07M
Median
41.29M
Minimum
35.51M
Maximum
54.17M
Discovering the peaks and valleys of Coya Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 35.77%
Maximum Annual Enterprise Value = 54.17M
Minimum Annual Increase = -21.19%
Minimum Annual Enterprise Value = 35.51M
Year | Enterprise Value | Change |
---|---|---|
2023 | 42.69M | -21.19% |
2022 | 54.17M | 35.77% |
2021 | 39.89M | 12.33% |
The current Enterprise Value of Coya Therapeutics, Inc. (COYA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
45.58M
5-year avg
43.07M
10-year avg
43.07M
Coya Therapeutics, Inc.’s Enterprise Value is less than Cue Biopharma, Inc. (71.55M), greater than Lantern Pharma Inc. (22.44M), less than Fennec Pharmaceuticals Inc. (113.39M), less than Eliem Therapeutics, Inc. (119.64M), less than Acumen Pharmaceuticals, Inc. (137.49M), less than Inozyme Pharma, Inc. (308.76M), less than Terns Pharmaceuticals, Inc. (505.29M), less than Day One Biopharmaceuticals, Inc. (1.08B), greater than Galera Therapeutics, Inc. (-6916978.00), greater than Cognition Therapeutics, Inc. (-8637153.00), greater than TFF Pharmaceuticals, Inc. (2.20M), less than TScan Therapeutics, Inc. (115.90M), greater than Dermata Therapeutics, Inc. (-3114171.00), less than NewAmsterdam Pharma Company N.V. (1.09B), less than Centessa Pharmaceuticals plc (1.76B), less than Sutro Biopharma, Inc. (395.53M), less than Opthea Limited (656.58M), greater than HilleVax, Inc. (36.48M), greater than Gain Therapeutics, Inc. (38.77M), less than aTyr Pharma, Inc. (138.44M), greater than IN8bio, Inc. (10.06M),
Company | Enterprise Value | Market cap |
---|---|---|
71.55M | $90.31M | |
22.44M | $35.20M | |
113.39M | $126.68M | |
119.64M | $342.68M | |
137.49M | $177.24M | |
308.76M | $277.29M | |
505.29M | $596.54M | |
1.08B | $1.50B | |
-6916978.00 | $2.64M | |
-8637153.00 | $19.27M | |
2.20M | $6.52M | |
115.90M | $266.98M | |
-3114171.00 | $1.83M | |
1.09B | $1.96B | |
1.76B | $1.80B | |
395.53M | $295.89M | |
656.58M | $628.43M | |
36.48M | $93.84M | |
38.77M | $54.90M | |
138.44M | $131.12M | |
10.06M | $14.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Coya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Coya Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Coya Therapeutics, Inc. (COYA)?
What is the 3-year average Enterprise Value for Coya Therapeutics, Inc. (COYA)?
What is the 5-year average Enterprise Value for Coya Therapeutics, Inc. (COYA)?
How does the current Enterprise Value for Coya Therapeutics, Inc. (COYA) compare to its historical average?